HIEMSTRA; Ida
Patent Applications and Registrations
Patent applications and USPTO patent grants for HIEMSTRA; Ida.The latest application filed is for "bispecific antibody against cd3 and cd20 in combination therapy for treating follicular lymphoma".
- HIEMSTRA; Ida - Utrecht NL
| Patent | Date |
|---|---|
| Bispecific Antibody Against Cd3 And Cd20 In Combination Therapy For Treating Follicular Lymphoma App 20220144964 - ELLIOTT; Brian ; et al. | 2022-05-12 |
| Bispecific Antibody Against Cd3 And Cd20 In Combination Therapy For Treating Diffuse Large B-cell Lymphoma App 20220119544 - Elliott; Brian ; et al. | 2022-04-21 |
| Bispecific Antibodies Against Cd3 And Cd20 For Treating Chronic Lymphocytic Leukemia App 20220112287 - Elliott; Brian ; et al. | 2022-04-14 |
| Bispecific Antibodies Against Cd3 And Cd20 App 20210371538 - AHMADI; Tahamtan ; et al. | 2021-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 